Literature DB >> 6728144

Percutaneous retrogasserian glycerol rhizotomy for tic douloureux: Part 1. Technique and results in 112 patients.

L D Lunsford, M H Bennett.   

Abstract

The technique and results of treatment of tic douloureux by percutaneous retrogasserian glycerol rhizotomy ( PRGR ) were assessed in a series of 112 patients. All patients were refractory to or intolerant of medical therapy. Many of these patients had recurrent pain despite such surgical treatment as microvascular decompression (21%) or one or more percutaneous radiofrequency thermal rhizotomies (19%). The follow-up duration after glycerol rhizotomy ranged from 4 to 28 months. At the final assessment, 67% had complete pain relief; 23% were improved, with pan relieved by minimal drug therapy; and 10% had poor results with unsatisfactory pain relief even with medications. Before the final assessment, 19 patients required a second PRGR because of an initially suboptimal injection (10%) or recurrent pain (16.9%). Seventy-three per cent had no demonstrable change in facial sensation after operation. H akanson 's original procedure based on anatomic verification by cisternography provided precise localization, required no intraoperative stimulation or lesion generators, and allowed varied anesthetic options during operation. In contrast to thermal rhizotomy, PRGR offers patients relief of painful tic douloureux without altering facial sensation in most cases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728144     DOI: 10.1227/00006123-198404000-00006

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Painful tic convulsif caused by an arteriovenous malformation.

Authors:  Byung-chul Son; Deog-ryung Kim; Jae-hoon Sung; Sang-won Lee
Journal:  Clin Neuroradiol       Date:  2012-08-18       Impact factor: 3.649

2.  Recurrent trigeminal cistern glycerol injections for tic douloureux.

Authors:  Z H Rappaport; J M Gomori
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

3.  Reterogasserian anhydrous glycerol injection therapy in trigeminal neuralgia: observations in 552 patients.

Authors:  S S Saini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

4.  Cryotherapy in the management of paroxysmal trigeminal neuralgia.

Authors:  J M Zakrzewska
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-04       Impact factor: 10.154

5.  Infratemporal Fossa Vascular Anatomy Pertinent to Percutaneous Access to the Foramen Ovale for Treatment of Trigeminal Neuralgia: A Comparison of Cadaveric Dissection and Computed Tomography Analysis.

Authors:  Jesse D Lawrence; Cletus Cheyuo; Robert A Marsh
Journal:  World Neurosurg       Date:  2022-01-10       Impact factor: 2.210

6.  High resolution CT of Meckel's cave.

Authors:  M Chui; W Tucker; A Hudson; N Bayer
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

7.  The Treatment Outcome of Elderly Patients with Idiopathic Trigeminal Neuralgia : Micro-Vascular Decompression versus Gamma Knife Radiosurgery.

Authors:  In Ho Oh; Seok Keun Choi; Bong Jin Park; Tae Sung Kim; Bong Arm Rhee; Young Jin Lim
Journal:  J Korean Neurosurg Soc       Date:  2008-10-30

8.  Role of transcutaneous electric nerve stimulation in the management of trigeminal neuralgia.

Authors:  Sanju Singla; Vikram Prabhakar; Rajan Kumar Singla
Journal:  J Neurosci Rural Pract       Date:  2011-07

Review 9.  Advances in diagnosis and treatment of trigeminal neuralgia.

Authors:  Nicola Montano; Giulio Conforti; Rina Di Bonaventura; Mario Meglio; Eduardo Fernandez; Fabio Papacci
Journal:  Ther Clin Risk Manag       Date:  2015-02-24       Impact factor: 2.423

10.  Cost-effectiveness analysis for trigeminal neuralgia: Cyberknife vs microvascular decompression.

Authors:  Rosanna Tarricone; Giovanni Aguzzi; Francesco Musi; Laura Fariselli; Andrea Casasco
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.